Trump Loyalists Mucked with MMWR; Global Cases Spike; JAK Inhibitor Win in COVID Trial

Note that some links may require registration or subscription.

White House appointees in the Department of Health and Human Services tried to alter the CDC’s Morbidity and Mortality Weekly Report, saying the scientists’ conclusions contradicted the president’s optimistic messages about COVID-19. (Politico)

As of Monday at 8:00 a.m. EDT, the unofficial COVID-19 toll in the U.S. was 6,520,606 cases, and 194,084 deaths — averaging about 36,000 and 800 daily, respectively, over the past week.

And the World Health Organization (WHO) reported a record one-day rise in coronavirus infections: about 308,000 new cases in 24 hours, with India, the U.S. and Brazil reporting the biggest increases. (BBC)

H. Holden Thorp, PhD, editor-in-chief of Science, did not mince words in his editorial’s headline: “Trump lied about science.”

If you believe Florida Gov. Ron DeSantis (R), airplanes are not COVID-19 “vectors.” Here’s what actual epidemiologists think. (Kaiser Health News)

Speaking of Florida: in part due to excessively long test processing times, contact tracing attempts in the state are apparently a “hot mess.” (WTSP)

Eli Lilly said its JAK inhibitor baricitinib (Olumiant), tested in the NIAID’s ACTT-2 trial as a COVID-19 therapy, showed modest benefit in hospitalized patients.

After being “voluntarily paused,” the AstraZeneca-Oxford vaccine trial resumes in Britain, the company said.

Not to be outdone, Pfizer and BioNTech said they are increasing the number of participants in their phase III trial from 30,000 to 44,000. (STAT)

But some experts say vaccine companies should be more transparent about how vaccine trials are being run. (New York Times)

Air pollution in certain Louisiana and New York counties was correlated with disproportionately higher rates of COVID-19 deaths. (ProPublica)

The virus is also killing people around the world through increased hunger and food insecurity. (New York Times)

In other news:

Last Updated September 14, 2020

  • author['full_name']

    Molly Walker is an associate editor, who covers infectious diseases for MedPage Today. She has a passion for evidence, data and public health. Follow